1
Carvedilol for Prevention of Esophageal Varices Progression
Condition(s):Cirrhosis, Liver; Portal HypertensionLast Updated:December 1, 2022Active, not recruiting
Carvedilol: 244 Clinical Trials, Page 1 of 25
Hide Studies Not Open or Pending
2
Acute Hemodynamic Response to Carvedilol in Children With Clinically Significant Portal Hypertension.
Condition(s):Portal HypertensionLast Updated:March 14, 2023Not yet recruiting
3
The Impact of Carvedilol Posology on Clinically Significant Portal Hypertension
Condition(s):Clinically Significant Portal HypertensionLast Updated:August 29, 2023Completed
4
Risk-Guided Cardioprotection With Carvedilol in Breast Cancer Patients Treated With Doxorubicin and/or Trastuzumab
Condition(s):Cardiotoxicity; Risk Factor, Cardiovascular; Toxicity Due to Chemotherapy; Breast Cancer; Cardiomyopathies; Heart FailureLast Updated:October 17, 2022Active, not recruiting
5
Carvedilol With Chemotherapy in Second Line Glioblastoma and Response of Circulating Tumor Cells
Condition(s):Glioblastoma Multiforme; GlioblastomaLast Updated:September 24, 2021Terminated
6
Anti-Cancer Effects of Carvedilol With Standard Treatment in Glioblastoma and Response of Peripheral Glioma Circulating Tumor Cells
Condition(s):Glioblastoma; Glioblastoma MultiformeLast Updated:April 12, 2021Withdrawn
7
Carvedilol in HF With Preserved EF
Condition(s):Heart Failure With Preserved Ejection Fraction; Beta Blocker; Myocardial StrainLast Updated:October 20, 2022Recruiting
8
Effects of Carvedilol on Suppressing the Premature Ventricular Complex/Ventricular Tachycardia From Outflow Tract
Condition(s):Ventricular Premature Complexes; Outflow Tract; CarvedilolLast Updated:July 18, 2018Unknown status
9
Extension Study of Carvedilol RCT Study
Condition(s):Liver Cirrhosis; Portal HypertensionLast Updated:August 25, 2021Recruiting
10
Are Carvedilol and Metoprolol Succinate Comparable Treatments in Heart Failure Patients With Reduced Ejection Fraction
Condition(s):Chronic Heart FailureLast Updated:August 16, 2021Not yet recruiting